Page last updated: 2024-12-04

3-cresol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-cresol: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

m-cresol : A cresol with the methyl substituent at position 3. It is a minor urinary metabolite of toluene. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID342
CHEMBL ID298312
CHEBI ID17231
SCHEMBL ID10736
SCHEMBL ID7410931
MeSH IDM0124405

Synonyms (111)

Synonym
AC-14350
CHEBI:17231 ,
metacresol
m-cresylic
m-hydroxytoluene
wln: qr c1
phenol, 3-methyl-
m-cresole
nsc8768
cresol, meta
nsc-8768
D04951
metacresol (usp)
inchi=1/c7h8o/c1-6-3-2-4-7(8)5-6/h2-5,8h,1h
toluene,3-hydroxy (meta-cresol)
CRS ,
rover's dog shampoo
franklin cresolis
celcure dry mix (chemicals for wood preserving)
ccris 645
hsdb 1815
epa pesticide chemical code 022102
nsc 8768
ai3-00136
fema no. 3530
caswell no. 261a
m-kresol [german]
einecs 203-577-9
cresol, m-isomer
cresol, m-
1-methyl-3-hydroxybenzene
m-kresol
hydroxy-3-methylbenzene
m-toluol
m-methylphenol
m-cresylic acid
meta-cresylic acid
3-hydroxytoluene
108-39-4
m-cresol
3-methyl-1-hydroxybenzene
m-oxytoluene
1-hydroxy-3-methylbenzene
3-cresol
C01467
meta-cresol
3-methylphenol
m-cresol, >=98%, fg
3-methylphenol, analytical standard
DB01776
NCGC00159366-02
NCGC00159366-05
NCGC00159366-03
NCGC00159366-04
CHEMBL298312 ,
BMSE000350
bdbm50008548
AKOS000119006
A801870
NCGC00159366-06
NCGC00256824-01
cas-108-39-4
dtxsid6024200 ,
tox21_302645
dtxcid804200
tox21_201941
NCGC00259490-01
AM62795
ggo4y809lo ,
ec 203-577-9
unii-ggo4y809lo
metacresol [usp:ban]
m-cresol [un2076] [poison, corrosive]
FT-0628174
amylmetacresol impurity b [ep impurity]
metacresol [usp monograph]
metacresol [hsdb]
m-cresol [who-dd]
metacresol [ep monograph]
metacresol [ep impurity]
metacresol [usp impurity]
m-cresol [inci]
metacresol [usp-rs]
metacresol [ii]
SCHEMBL10736
SCHEMBL7410931
meta cresol
3-methyl-phenol
3-methyl phenol
3methylphenol
cresol,m-
m-cresol;
J-002137
J-521679
CCG-230271
m-cresol, reagent grade, 97%
m-cresol, 99%
F0001-0167
mfcd00002302
m-cresol, saj first grade, >=97.0%
metacresol, united states pharmacopeia (usp) reference standard
m-cresol, analytical standard
m-cresol, for synthesis, 99%
metacresol (3-methylphenol)
metacresol; 3-methylphenol; amylmetacresol impurity b
3-methylphenol 100 microg/ml in methanol
Q312240
STL185666
BS-23591
EN300-19428
Z104473820

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" In Study A, four males were exposed to clean air and to constant and varying concentrations of toluene in combination with rest and with 100 W exercise in 140 min."( Toluene metabolism during exposure to varying concentrations combined with exercise.
Andersen, NT; Baelum, J; Døssing, M; Hansen, SH; Lundqvist, GR, 1987
)
0.27

Dosage Studied

ExcerptRelevanceReference
" At 100 mg/kg, hypersensitivity and tremors were also noted in a small number of males only on single days during the dosing period."( Higher susceptibility of newborn than young rats to 3-methylphenol.
Ema, M; Fujii, S; Furukawa, M; Hasegawa, R; Ito, Y; Kamata, E; Koizumi, M; Noda, A, 2003
)
0.32
"Multidose formulations of biotherapeutics, which offer better dosage management and reduced production costs, require the addition of antimicrobial preservatives (APs)."( Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
Arora, J; Joshi, SB; Middaugh, CR; Volkin, DB; Weis, DD, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cresolA hydroxytoluene that consists of toluene carrying a single hydroxy substituent at any position. A 'closed class'.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
patulin biosynthesis532
m-cresol degradation116

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.24340.000714.592883.7951AID1259369
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.90600.000817.505159.3239AID1159527; AID588544
pregnane X nuclear receptorHomo sapiens (human)Potency827.84230.005428.02631,258.9301AID720659
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency61.64480.001024.504861.6448AID743212
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency2.85560.023723.228263.5986AID743223
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.03980.010039.53711,122.0200AID588545
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency354.81300.000627.21521,122.0200AID651741
DNA polymerase kappa isoform 1Homo sapiens (human)Potency37.68580.031622.3146100.0000AID588579
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency2.51190.251215.843239.8107AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)2.47290.00000.933210.0000AID32248; AID32280
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1134603Oleyl alcohol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1186380Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Antileishmanial metabolites from Geosmithia langdonii.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID335129Antifungal activity against Trichophyton mentagrophytes 10100 at 60 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID32280IC50 against acetylcholinesterase; value ranges from 1-4900 nM.1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID335125Antifungal activity against Candida albicans 10261 at 300 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID1149269Antimicrobial activity against Aspergillus niger1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Quantitative structure-activity relationships. 2. A mixed approach, based on Hansch and Free-Wilson Analysis.
AID401415Inhibition of bovine brain PI-PLCgamma11998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID335119Antibacterial activity against Bacillus subtilis at 60 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID32248Inhibition of acetylcholinesterase.1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID335120Antibacterial activity against Bacillus subtilis at 300 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID335115Antifungal activity against Cladosporium resinae 10100 at 60 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID335124Antifungal activity against Candida albicans 10261 at 60 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID282834Activity against caspase-mediated apoptosis in mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID335114Antibacterial activity against Escherichia coli at 60 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID335106Cytotoxicity against african green monkey BSC cells at 60 ug/mL after 24 hrs1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID335130Antifungal activity against Trichophyton mentagrophytes 10100 at 300 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (15.15)18.7374
1990's19 (19.19)18.2507
2000's19 (19.19)29.6817
2010's21 (21.21)24.3611
2020's25 (25.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.15 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index49.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.96%)6.00%
Case Studies2 (1.98%)4.05%
Observational0 (0.00%)0.25%
Other95 (94.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]